{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T18:54:46Z","timestamp":1789412086707,"version":"build-2803163510"},"reference-count":22,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,5,3]],"date-time":"2025-05-03T00:00:00Z","timestamp":1746230400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Arthritis and Rheumatism"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.semarthrit.2025.152749","type":"journal-article","created":{"date-parts":[[2025,5,3]],"date-time":"2025-05-03T15:41:02Z","timestamp":1746286862000},"page":"152749","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Trial-level factors affecting accrual rate of systemic sclerosis randomized clinical trials"],"prefix":"10.1016","volume":"73","author":[{"given":"Barbara","family":"Russo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iulia-Simona","family":"Chiric\u0103","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Delphine Sophie","family":"Courvoisier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5871-8806","authenticated-orcid":false,"given":"Michele","family":"Iudici","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.semarthrit.2025.152749_bib0001","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1002\/acr.24854","article-title":"Extent of and reasons for discontinuation and nonpublication of interventional trials on connective tissue diseases: an observational study","volume":"75","author":"Brigante","year":"2023","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"10.1016\/j.semarthrit.2025.152749_bib0002","doi-asserted-by":"crossref","DOI":"10.1016\/j.conctc.2021.100829","article-title":"Barriers and facilitators to the participation of subjects in clinical trials: an overview of reviews","volume":"23","author":"Rodr\u00edguez-Torres","year":"2021","journal-title":"Contemp Clin Trial Commun"},{"key":"10.1016\/j.semarthrit.2025.152749_bib0003","doi-asserted-by":"crossref","DOI":"10.1016\/j.conctc.2021.100843","article-title":"Trial-level factors affecting accrual and completion of oncology clinical trials: a systematic review","volume":"24","author":"Hauck","year":"2021","journal-title":"Contemp Clin Trial Commun"},{"key":"10.1016\/j.semarthrit.2025.152749_bib0004","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/1471-2288-14-10","article-title":"Factors influencing recruitment to research: qualitative study of the experiences and perceptions of research teams","volume":"14","author":"Newington","year":"2014","journal-title":"BMC Med Res Methodol"},{"key":"10.1016\/j.semarthrit.2025.152749_bib0005","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/djv324","article-title":"Predicting low accrual in the National Cancer Institute's Cooperative group clinical trials","volume":"108","author":"Bennette","year":"2016","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.semarthrit.2025.152749_bib0006","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2022-064458","article-title":"What drives cancer clinical trial accrual? An empirical analysis of studies leading to FDA authorisation (2015-2020)","volume":"12","author":"Jenei","year":"2022","journal-title":"BMJ Open"},{"key":"10.1016\/j.semarthrit.2025.152749_bib0007","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1093\/annonc\/mdx793","article-title":"Crossover is not associated with faster trial accrual","volume":"29","author":"Chen","year":"2018","journal-title":"Ann Oncol"},{"key":"10.1016\/j.semarthrit.2025.152749_bib0008","doi-asserted-by":"crossref","DOI":"10.1007\/s11523-024-01081-w","article-title":"Patient enrollment per month (Accrual) in clinical trials leading to the FDA approval of new cancer drugs","author":"Michaeli","year":"2024","journal-title":"Target Oncol"},{"key":"10.1016\/j.semarthrit.2025.152749_bib0009","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1056\/NEJMra0806188","article-title":"Scleroderma","volume":"360","author":"Gabrielli","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.semarthrit.2025.152749_bib0010","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1002\/acr.23817","article-title":"Ten years of interventional research in systemic sclerosis: a systematic mapping of trial registries","volume":"72","author":"Iudici","year":"2020","journal-title":"Arthrit Care Res (Hoboken)"},{"key":"10.1016\/j.semarthrit.2025.152749_bib0011","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/j.semarthrit.2025.152749_bib0012","first-page":"130","article-title":"How to identify randomized controlled trials in MEDLINE: ten years on","volume":"94","author":"Glanville","year":"2006","journal-title":"J Med Libr Assoc"},{"key":"10.1016\/j.semarthrit.2025.152749_bib0013","doi-asserted-by":"crossref","first-page":"2543","DOI":"10.1001\/jama.299.21.2543","article-title":"Patient-important outcomes in registered diabetes trials","volume":"299","author":"Gandhi","year":"2008","journal-title":"JAMA"},{"key":"10.1016\/j.semarthrit.2025.152749_bib0014","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.1002\/acr.25059","article-title":"Reporting and representativeness of race, ethnicity, and socioeconomic status in systemic sclerosis randomized trials: an observational study","volume":"75","author":"Chaix","year":"2023","journal-title":"Arthrit Care Res (Hoboken)"},{"issue":"1","key":"10.1016\/j.semarthrit.2025.152749_bib0015","doi-asserted-by":"crossref","DOI":"10.1136\/bmjmed-2022-000158","article-title":"Designing and conducting adaptive trials to evaluate interventions in health services and implementation research: practical considerations","volume":"1","author":"Lauffenburger","year":"2022","journal-title":"BMJ Med"},{"key":"10.1016\/j.semarthrit.2025.152749_bib0016","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1177\/1740774514558307","article-title":"Unsuccessful trial accrual and human subjects protections: an empirical analysis of recently closed trials","volume":"12","author":"Carlisle","year":"2015","journal-title":"Clin Trial"},{"key":"10.1016\/j.semarthrit.2025.152749_bib0017","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1186\/s12874-020-00979-z","article-title":"Study design factors influencing patients' willingness to participate in clinical research: a randomised vignette-based study","volume":"20","author":"Gayet-Ageron","year":"2020","journal-title":"BMC Med Res Methodol"},{"key":"10.1016\/j.semarthrit.2025.152749_bib0018","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1038\/nrd.2017.65","article-title":"Trial watch: trends in clinical trial design complexity","volume":"16","author":"Getz","year":"2017","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.semarthrit.2025.152749_bib0019","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0271819","article-title":"Changes in key recruitment performance metrics from 2008 to 2019 in industry-sponsored phase III clinical trials registered at ClinicalTrials.Gov","volume":"17","author":"Br\u00f8gger-Mikkelsen","year":"2022","journal-title":"PLoS One"},{"key":"10.1016\/j.semarthrit.2025.152749_bib0020","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2017-017246","article-title":"Strategies for developing sustainable health research capacity in low and middle-income countries: a prospective, qualitative study investigating the barriers and enablers to locally led clinical trial conduct in Ethiopia, Cameroon and Sri Lanka","volume":"7","author":"Franzen","year":"2017","journal-title":"BMJ Open"},{"key":"10.1016\/j.semarthrit.2025.152749_bib0021","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1016\/j.pec.2020.03.018","article-title":"Patients' understanding of oncology clinical endpoints: a literature review","volume":"103","author":"Boudewyns","year":"2020","journal-title":"Patient Educ Couns"},{"key":"10.1016\/j.semarthrit.2025.152749_bib0022","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1093\/rheumatology\/keab437","article-title":"Representativeness of systemic sclerosis patients in interventional randomized trials: an analysis of the EUSTAR database","volume":"61","author":"Iudici","year":"2022","journal-title":"Rheumatol (Oxf)"}],"container-title":["Seminars in Arthritis and Rheumatism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049017225001209?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049017225001209?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,4]],"date-time":"2025-07-04T02:00:22Z","timestamp":1751594422000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049017225001209"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":22,"alternative-id":["S0049017225001209"],"URL":"https:\/\/doi.org\/10.1016\/j.semarthrit.2025.152749","relation":{},"ISSN":["0049-0172"],"issn-type":[{"value":"0049-0172","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Trial-level factors affecting accrual rate of systemic sclerosis randomized clinical trials","name":"articletitle","label":"Article Title"},{"value":"Seminars in Arthritis and Rheumatism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.semarthrit.2025.152749","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"152749"}}